学术探索
学术期刊
新闻热点
数据分析
智能评审

Activated T cells and cytokine-induced CD3(+)CD56(+) killer cells

被引：218
作者：
SchmidtWolf, GD
Negrin, RS
SchmidtWolf, IGH
机构：
[1] HUMBOLDT UNIV BERLIN,VIRCHOW CLIN,DEPT MED,DIV HEMATOL ONCOL,D-13353 BERLIN,GERMANY
[2] STANFORD UNIV,MED CTR,BONE MARROW TRANSPLANTAT PROGRAM,STANFORD,CA 94305
来源：
ANNALS OF HEMATOLOGY | 1997年 / 74卷 / 02期
关键词：
T cells; cytokine-induced killer cells; immunotherapy;
D O I：
10.1007/s002770050257
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Over the past two decades, attempts have been made to develop immunotherapy for patients with cancer. A significant obstacle to the development of successful adoptive immunotherapy has been the availability of appropriate cytotoxic cells. Immunologic effector cells such as lymphokine-activated killer (LAK) cells, activated T cells such as tumor-infiltrating lymphocytes (TILs), and cytokine-induced killer (CIK) cells may be suitable to remove residual tumor cells.
引用
收藏
页码：51 / 56
页数：6
相关论文
共 49 条
  • [1] ALDER A, 1988, BLOOD, V71, P709
  • [2] INDUCIBILITY OF LYMPHOKINE ACTIVATED KILLER (LAK) CELLS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA IN COMPLETE REMISSION AND ITS CLINICAL RELEVANCE
    ARCHIMBAUD, E
    BAILLY, M
    DORE, JF
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1991, 77 (03) : 328 - 334
  • [3] BALLAS ZK, 1987, J IMMUNOL, V139, P3542
  • [4] T-CELL TARGETING IN CANCER-THERAPY
    BOLHUIS, RLH
    STURM, E
    BRAAKMAN, E
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1991, 34 (01) : 1 - 8
  • [5] CSIPAI M, 1996, IN PRESS CANC RES TH
  • [6] TREATMENT OF CANCER-PATIENTS WITH EXVIVO ANTI-CD3-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2
    CURTI, BD
    LONGO, DL
    OCHOA, AC
    CONLON, KC
    SMITH, JW
    ALVORD, WG
    CREEKMORE, SP
    FENTON, RG
    GAUSE, BL
    HOLMLUND, J
    JANIK, JE
    OCHOA, J
    RICE, PA
    SHARFMAN, WH
    SZNOL, M
    URBA, WJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (04) : 652 - 660
  • [7] GENERATION OF LEUKEMIA-REACTIVE CYTOTOXIC LYMPHOCYTE-T CLONES FROM THE HLA-IDENTICAL BONE-MARROW DONOR OF A PATIENT WITH LEUKEMIA
    FABER, LM
    VANLUXEMBURGHEIJS, SAP
    WILLEMZE, R
    FALKENBURG, JHF
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) : 1283 - 1289
  • [8] FIERRO MT, 1988, LEUKEMIA, V2, P50
  • [9] FINKE S, 1995, UNPUB BLOOD
  • [10] LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON .3. EVIDENCE THAT IL-2 IS SUFFICIENT FOR DIRECT ACTIVATION OF PERIPHERAL-BLOOD LYMPHOCYTES INTO LYMPHOKINE-ACTIVATED KILLER CELLS
    GRIMM, EA
    ROBB, RJ
    ROTH, JA
    NECKERS, LM
    LACHMAN, LB
    WILSON, DJ
    ROSENBERG, SA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (04) : 1356 - 1361
12345